| CPC A61N 2/002 (2013.01) [A61K 35/12 (2013.01); A61K 35/16 (2013.01); A61K 35/28 (2013.01); A61K 38/18 (2013.01); A61K 38/193 (2013.01); A61N 2/02 (2013.01)] | 19 Claims |
|
1. A method of treating an aging subject comprising:
a) preparing an allogeneic stem cell rich plasma composition by administering to a young healthy donor a stem cell mobilization agent in an amount and for a time period sufficient to stimulate a significantly increased number of stem cells in the blood of the donor, wherein the stem cell mobilization agent is a granulocyte colony stimulating factor (G-CSF);
b) obtaining a sufficient volume of plasma by plasmapheresis from the donor blood by separating cellular material from the blood and retaining the stem cell rich plasma; and
c) administering the allogeneic stem cell rich plasma composition to the aging recipient who has the ABO/Rh blood type of said donor, wherein upon administration of the plasma to the aging recipient in need thereof, the plasma induces a change in at least one or a combination of biomarkers, thereby treating the aging subject.
|